Company description

AmpleLogic is a leading automation solutions provider for pharmaceutical industry. It has a unique visual development, drag & drop feature with intuitive interface, where 36 data components are available to accommodate data verification & validation which shortens the application development time. Our 21 CFR Part 11 compliant and EU Annex 11 solutions are in use at more than 17 US FDA, 3 MHRA and 10 WHO approved units. AmpleLogic has tweaked traditional V Model to accelerate GMP Automations and address data integrity issues with unique No/ Low Code Platform by adding the Configuration and Experimentation phase in the implementation cycle which address regulatory audit observations related to revalidation, deviations and multiple release managements results in implementation time reduction by 70%. A strong focus in Pharma domain made us to build 14 ready to use apps to fulfill the need of QA, QC and Production area. Our pharma software solutions (QMS Automation, Batch Record Issuance Software, Quality Control Automation, ANDA and DMF Tracker Software, Calibration Schedules Tracking Software, Training Management System, Electronic Batch Recording Software and Artwork Management Software) implemented at US FDA, MHRA and WHO approved manufacturers in most of the Pharma and Life Science sectors. We at AmpleLogic have received 100% user acceptance from our existing customers, which proves NO PROJECT FAILURES till date.

Quick facts

Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Affiliated categories: Platform technologies |Process Automation & Controls |Technology and software More

Recently at

5 nov 2019

CPhI Worldwide 2019

5-7 November 2019 Frankfurt, Germany We were at stand 121A65 See our Exhibitor Profile   See full Exhibitor List

News about Amplelogic

Tweaking V Model to Accelerate GMP Automation’s & Address Data Integrity Issues

28 Aug 2018

Tweaking V Model to Accelerate GMP Automation’s & Address Data Integrity Issues

A long list of data integrity warnings received by pharma companies have made them train their focus on building and fortifying their tracking mechanisms to prevent things from going wrong. One of the solutions is digitization and building a data repository to make it easily available to analyse issues and predict challenges.

Read more

Contact information




View all contact information